Compass Therapeutics, Inc. Share Price
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.330 USD | +0.87% |
|
+2.64% | -56.61% |
| 29/06 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000E Growth Benchmark | CI |
| 29/06 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000 Growth Benchmark | CI |
| Market Cap | 42Cr 37Cr 34Cr 31Cr 59Cr 4TCr 60Cr 404.49Cr 158.85Cr 1.97TCr 157.55Cr 154.12Cr 6.78TCr | P/E 2026 * |
-5.34x | P/E 2027 * | -5.01x |
|---|---|---|---|---|---|
| Enterprise Value | 27Cr 24Cr 22Cr 20Cr 38Cr 2.57TCr 39Cr 259.9Cr 102.06Cr 1.27TCr 101.23Cr 99Cr 4.35TCr | EV / Sales 2026 * |
-131x | EV / Sales 2027 * | 11.4x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compass Therapeutics, Inc.
| 1 day | +0.87% | ||
| 1 week | +2.64% | ||
| Current month | +6.39% | ||
| 1 month | +15.92% | ||
| 3 months | -54.93% | ||
| 6 months | -56.45% | ||
| Current year | -56.61% |
| 1 week | 2.15 |  | 2.36 |
| 1 month | 1.96 | | 2.36 |
| Current year | 1.61 | | 6.88 |
| 1 year | 1.61 | | 6.88 |
| 3 years | 0.76 | | 6.88 |
| 5 years | 0.76 | | 6.88 |
| 10 years | 0.76 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 28/05/2024 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 09/12/2024 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 01/01/2014 |
Phil Ferneau
BRD | Director/Board Member | 64 | 01/01/2015 |
Carl Gordon
CHM | Chairman | 61 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/04 | Buy | Controller/Auditor | 15,000 | 0.0083% | ||
| 29/04 | Buy | General Counsel | 25,000 | 0.0139% | ||
| 08/02 | Tax | Chief Executive Officer | 36,687 | 0.0206% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.87% | +2.64% | -13.70% | -18.25% | 42Cr | |
| +1.84% | -0.66% | +59.82% | +92.96% | 5.49TCr | |
| -4.14% | -8.06% | +58.96% | +118.67% | 5.46TCr | |
| -2.24% | +3.59% | +17.75% | +477.47% | 2.51TCr | |
| -1.60% | -6.21% | -18.96% | -15.21% | 2.31TCr | |
| +2.43% | +1.06% | +42.44% | -1.27% | 1.99TCr | |
| -3.19% | 0.00% | +35.60% | -26.98% | 1.75TCr | |
| -6.84% | +2.18% | +195.12% | +357.18% | 1.65TCr | |
| +8.74% | +3.51% | +51.91% | +726.40% | 1.57TCr | |
| -1.05% | +1.16% | +25.95% | +194.27% | 1.42TCr | |
| Average | -0.52% | +0.01% | +45.49% | +190.52% | 2.42TCr | |
| Weighted average by Cap. | -0.89% | -1.44% | +51.15% | +176.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | -20.57L -17.99L -16.6L -15.33L -29.09L -20Cr -29.58L -1.98Cr -77.88L -9.67Cr -77.24L -75.56L -33Cr | 2.53Cr 2.21Cr 2.04Cr 1.88Cr 3.57Cr 241Cr 3.63Cr 24Cr 9.57Cr 118.72Cr 9.49Cr 9.28Cr 408.15Cr |
| Net income | -8.24Cr -7.21Cr -6.65Cr -6.14Cr -12Cr -786.24Cr -12Cr -79Cr -31Cr -387.32Cr -31Cr -30Cr -1.33TCr | -8.96Cr -7.83Cr -7.23Cr -6.67Cr -13Cr -854.24Cr -13Cr -86Cr -34Cr -420.83Cr -34Cr -33Cr -1.45TCr |
| Net Debt | -15Cr -13Cr -12Cr -11Cr -21Cr -1.43TCr -22Cr -144.6Cr -57Cr -704.76Cr -56Cr -55Cr -2.42TCr | -13Cr -12Cr -11Cr -9.84Cr -19Cr -1.26TCr -19Cr -127.25Cr -50Cr -620.19Cr -50Cr -48Cr -2.13TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $2.330 | +0.87% | 27,97,353 |
| 09/26/09 | $2.310 | -1.28% | 19,72,847 |
| 08/26/08 | $2.340 | +0.86% | 38,81,914 |
| 07/26/07 | $2.320 | +1.31% | 32,12,752 |
| 06/26/06 | $2.290 | +0.88% | 24,81,789 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
